SAN FRANCISCO, CA, UNITED STATES, September 24, 2025 /EINPresswire.com/ -- RhythmScience, a leader in cardiac data management solutions, today announced it has ...

ISSAQUAH, Wash.--(BUSINESS WIRE)--BaroPace Inc. announces its Phase I first-in-human trial of PressurePace TM, its patent-pending pacemaker control algorithm for the treatment of heart failure with ...

Panelists discuss how effective heart failure management requires collaborative care across multiple specialties (primary care, cardiology, endocrinology, nephrology) with advanced practice providers ...

The diagnostics advisory committee looked at evidence on algorithm-based remote monitoring of heart failure in people with cardiac implantable electronic devices (CIEDs). Evidence was considered from ...

A non-randomized, double-blind study of 521 patients with heart failure found that the combination of data from minute ventilation and physical activity sensors could predict 34 percent of heart ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Inconsistent adherence to the guidelines led to delayed heart failure treatment optimization and underutilization of key therapies. Published in the European Journal of Heart Failure, the survey ...

Berlin: Bayer has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for finerenone (Kerendia), a ...

Adults who have heart failure with a left ventricular ejection fraction of 40% or more face a high risk of hospitalization for heart failure and cardiovascular death. People who have heart failure ...

Advanced heart failure is when heart failure progresses to the most severe stage. When you have advanced heart failure, your blood pressure, blood flow, kidney and liver function, exercise capacity, ...

conditions affecting the heart muscle (cardiomyopathies and myocarditis). Around 920,000 people in the UK were living with heart failure in 2018 with an estimated 200,000 new diagnoses each year.